Table 1.

Clinical assessment and neuroimaging at baseline and follow-up

Baseline
Clinical assessment	Demographics, risk factors, medication, medical history, NIHSS
Neuro-imaging	Unenhanced CT and CT angiography*
Follow-up
Clinical assessment at 24 hours	NIHSS. Adverse events.
Neuro-imaging at 24 hours	CT angiography*
Neuro-imaging at 5-7 days	Unenhanced CT or MRI
Clinical assessment at 1 week or discharge	NIHSS; Barthel index
Clinical assessment at 90 days	Modified Rankin score, Barthel index, EQ5D

*Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) are allowed; computed tomography (CT) perfusion is recommended but not obligatory. EQ-5D, EuroQol 5D measurement tool for health-related quality of life; NIHSS, National Institutes of Health stroke scale.